Jenny Belitz, PA
Medical · Fremont, NENPI 1427062538
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 342 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 40 manufacturers reported payments, led by AbbVie at 29.2% of the total. 2025 is the largest year on record at $1,396, 2.7 times the $514 reported in 2021. Among medical clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 342 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$667
- Otsuka America Pharmaceutical, Inc.$442
- Novo Nordisk$396
- Lilly USA, LLC$386
- Pfizer$346
- plus $1K from 34 others
What the payments were for
- Food & beverage$5,01698%
- Education$631%
- Other$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,124 in reported general payments places this provider in the 90th percentile of 216 medical providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 47 | $55,291 |
| VraylarCariprazine Hcl | 33 | $53,732 |
| JardianceEmpagliflozin | 52 | $51,640 |
| OzempicSemaglutide | 28 | $26,662 |
| FarxigaDapagliflozin Propanediol | 29 | $23,330 |
| EliquisApixaban | 22 | $18,263 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $17,275 |
| XareltoRivaroxaban | 12 | $14,591 |
| MyrbetriqMirabegron | 12 | $12,557 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $12,004 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $9,669 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $6,426 |
| Varenicline Tartrate | 17 | $5,606 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,604 |
| Atorvastatin Calcium | 407 | $3,507 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Synthroid | $1,496 | $55,52754 claims |
| Lilly USA, LLCMounjaro | $386 | $55,29147 claims |
| Boehringer IngelheimJardiance | $173 | $51,64052 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $152 | $50,27484 claims |
| Novo NordiskOzempic | $396 | $26,66228 claims |
| PfizerEliquis | $346 | $18,26322 claims |
| Johnson & JohnsonXarelto | $27 | $14,59112 claims |
| Astellas Pharma US IncMyrbetriq | $23 | $12,55712 claims |
| GSKBreo Ellipta | $14 | $5,60413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 216 medical providers in Nebraska.
Other medical in Fremont
- Lisa StenversFremont$4K
- Jessica FrancisFremont$3K
- Michelle SitzmanLincoln$206K
- Kaitlin MatthesLincoln$98K
- Kelly HooverOmaha$16K
- Lyndsey DegenhardtElkhorn$12K
- Jacob RidderOmaha$12K
- Angelika StevensOmaha$8K
- Jennelea MontanezOmaha$8K
- Shannon BusterPapillion$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.